|
Donald S. Baim M.D. is Executive Vice President Chief Medical and Scientific Officer at Boston Scientific Corporation as of July 3 2006.
Dr. Baim's primary responsibilities include management of Clinical Affairs (including pre-clinical and clinical studies); Medical Affairs (including educational programs and physician relationships) and Safety. He also plays a major role in developing technology strategies including the assessment of technologies of acquisition and partnership candidates and their integration with internal technologies to help develop the Company's future product portfolio.
Before joining Boston Scientific Dr. Baim was a Professor of Medicine at Harvard Medical School Senior Physician at the Brigham and Women's Hospital and an internationally recognized leader in interventional cardiology who specialized in the development and evaluation of new interventional cardiovascular devices. He has published nearly 300 scientific papers on interventional cardiology edited the leading textbook in the field (Grossman's Cardiac Catheterization Angiography and Intervention now in its 7th edition) and has served as a member of the Interventional Cardiology Test Committee of the American Board of Internal Medicine (ABIM). Dr. Baim has been the national Principal Investigator on literally dozens of clinical trials in interventional cardiology and a founder or key consultant for more than 20 start-up companies and medical device incubators in areas ranging from embolic protection thrombectomy chronic total occlusions arterial closure novel stent and coatings heart failure and percutaneous heart valves. He was the recipient of the Career Achievement Award at TCT 2000 based on his clinical research and educational contributions to the field.
Dr. Baim completed his undergraduate training in Physics at the University of Chicago and then received a M.D. from Yale University School of Medicine. During post-graduate training in medicine and cardiology at Stanford he worked with Dr. John Simpson during the development of some of the earliest moveable guidewire coronary angioplasty catheters. In 1981 Dr. Baim was recruited to establish an Interventional Cardiology program at Boston's Beth Israel Hospital. Under his leadership this program went on to perform seminal research in the refinement critical evaluation and optimal application of newer devices including stents atherectomy clot removal and distal embolic protection.
In 2000 he was recruited by the Brigham and Women's Hospital in Boston where in addition to his clinical responsibilities he directed the hospital's participation in the Center for the Integration of Medicine and Innovative Technology (CIMIT) a federally funded inter-disciplinary consortium of leading Boston teaching hospitals and engineering institutions that develops innovative device solutions for a wide range of unmet medical challenges. Since 2005 Dr. Baim has also served as Chief Academic Officer of the Harvard Clinical Research Institute (HCRI) a not-for-profit organization that designs conducts and analyzes pilot and pivotal trials of new medical devices to support their approval by the U.S. Food and Drug Administration (FDA). | 